Bladder Cancer

[Bladder Preservation or Initial Cystectomy in T1G3 Bladder Cancer: Which Parameters Help in Therape
PURPOSE: T1G3 bladder cancers show the clinical and biological behaviour of muscle invasive tumours with progression rates of about 30 %.


Germany
Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
PURPOSE: We compared recurrence patterns and survival of patients with urothelial bladder cancer undergoing radical cystectomy who either had limited or extended pelvic lymph node dissection at 2 institutions between 1987 and 2000.

Cleveland, OH
USA
The Schedule and Duration of Intravesical Chemotherapy in Patients with Non-Muscle-Invasive Bladder
OBJECTIVES: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; however, the optimal schedule and duration of treatment are unknown.

Brussels,
The Netherlands
Phase III Prevention Trial of Fenretinide in Patients with Resected Non Muscle-Invasive Bladder Canc
PURPOSE: The study aims to evaluate the efficacy and toxicity of fenretinide in preventing tumor recurrence in patients with transitional cell carcinoma (TCC) of the bladder.

TX
USA